Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Current Deferred Revenue (2019)

Avai Bio's Current Deferred Revenue history spans 1 years, with the latest figure at $6000.0 for Q1 2019.

  • On a quarterly basis, Current Deferred Revenue changed N/A to $6000.0 in Q1 2019 year-over-year; TTM through Mar 2019 was $6000.0, a N/A change, with the full-year FY2019 number at $6000.0, changed N/A from a year prior.
  • Current Deferred Revenue hit $6000.0 in Q1 2019 for Avai Bio.
  • Over the last five years, Current Deferred Revenue for AVAI hit a ceiling of $6000.0 in Q1 2019 and a floor of $6000.0 in Q1 2019.